Head-to-Head

ImmunityBio, Inc. Common Stock vs. Repligen Corp

IBRX

ImmunityBio, Inc. Common Stock

$8.22 -1.08%

VS RGEN

Repligen Corp

$178.88 +1.39%

ImmunityBio, Inc. Common Stock and Repligen Corp are evenly matched on the factors we track — the better pick depends on what you're optimizing for.

Size & Scale

IBRXRGEN
Market Cap $8.71 billion $11.20 billion

RGEN leads on 1 of 1 size & scale factors.

Risk & Sentiment

IBRXRGEN
Short Interest 0.42% 7.13%

IBRX leads on 1 of 1 risk & sentiment factors.

Dig deeper: IBRX overview, IBRX financials, RGEN overview, RGEN financials.

Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.